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L E T T E R  T O  T H E  E D I T O R
Assessing the protective role of allergic disease in 
gastrointestinal tract cancers using Mendelian randomization 
analysis
To the Editor,
Immune hypersensitivity featured among allergic individuals has 
been proposed to enhance immune surveillance, thereby inhibit-
ing abnormal cell growth and thus reduce cancer risk.1,2 Similarly, 
the prophylaxis theory suggests that allergy symptoms may pre-
vent cancer development by removing potential carcinogens.2 This 
hypothesis envisages a preventive role specifically for cancers of 
tissues that interface with the external environment, such as gas-
trointestinal tract cancers.2 A reduced risk of gastrointestinal tract 
cancer among individuals with self-reported allergic conditions 
has been observed in several but not all observational studies.3,4 
However, whether the associations are causal remains unclear as 
observational studies are prone to residual confounding. Therefore, 
we conducted a Mendelian randomization study5 to determine the 
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F I G U R E  1   Associations of genetic predisposition to allergic disease with esophageal, gastric, and colorectal cancer. BBJ, indicates 
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causal role of genetic liability to allergic disease in esophageal, gas-
tric, and colorectal cancers.
One hundred and thirty-six single-nucleotide polymorphisms 
(SNPs) associated with at least one allergic disease (asthma, aller-
gic rhinitis, or eczema) at P < 3×10−8 in 180 129 cases and 180 709 
non-cases of European ancestry were considered as instrumental 
variables.6 The 136 SNPs were independent and not in linkage dis-
equilibrium defined by distance >1 Mb and r2 < 0.02. The SNPs ex-
plained around 2.6% of phenotypic variance. Summary-level data 
for the associations of those SNPs with esophageal, gastric, and 
colorectal cancers were obtained from the UK Biobank, BioBank 
Japan, and FinnGen consortium. The main analysis was based on the 
multiplicative random-effects inverse-variance weighted method, and 
estimates from the different studies were combined using fixed ef-
fects meta-analysis. The inverse-variance weighted method under a 
fixed effects model and the weighted median, MR-Egger regression, 
and MR-PRESSO methods were employed as sensitivity analyses. The 
I2 (%) statistic and Cochrane's Q value were calculated to assess het-
erogeneity among estimates of individual SNPs. We considered as-
sociations with P values below .017 (where P = .05/3) to represent 
strong evidence of causal associations and associations with P values 
below .05 but above .017 as suggestive evidence of associations.
Genetic liability to allergic disease was associated with lower 
risk of the gastrointestinal tract cancers in the meta-analysis of UK 
TA B L E  1   Associations of genetic predisposition to allergic disease with esophageal, gastric, and colorectal cancer in sensitivity analyses
Esophageal cancer Gastric cancer Colorectal cancer




0.89 0.73, 1.08 .242 0.88 0.72, 1.09 .253 0.91 0.84, 0.98 .015
Weighted median 
method
0.92 0.69, 1.23 .571 0.84 0.61, 1.15 .270 0.96 0.84, 1.08 .489
MR-Egger regression 1.01 0.6, 1.68 .976 1.23 0.71, 2.13 .468 0.91 0.73, 1.15 .442
MR-PRESSO methoda  n/a n/a n/a n/a n/a n/a 0.90 0.83, 0.98 .012
Heterogeneityb  I2 = 0%; Cochrane's Q = 114; 
Phet = .877
I2 = 0%; Cochrane's Q = 137; 
Phet = .393
I2 = 21%; Cochrane's Q = 168; 
Phet = .021




0.79 0.66, 0.96 .017 0.88 0.81, 0.96 .004 0.91 0.83, 0.99 .022
Weighted median 
method
0.65 0.49, 0.86 .003 0.94 0.82, 1.07 .332 0.87 0.76, 0.99 .034
MR-Egger regression 0.65 0.37, 1.14 .130 0.83 0.61, 1.13 .237 0.84 0.66, 1.08 .181
MR-PRESSO methoda  n/a n/a n/a 0.93 0.84, 1.02 .138 n/a n/a n/a
Heterogeneityb  I2 = 0%; Cochrane's Q = 92; 
Phet = .833
I2 = 31%; Cochrane's Q = 154; 
Phet = .002
I2 = 3%; Cochrane's Q = 109; 
Phet = .407




0.93 0.52, 1.67 .803 1.11 0.79, 1.56 .537 0.93 0.79, 1.09 .352
Weighted median 
method
0.79 0.34, 1.85 .586 1.21 0.72, 2.02 .477 1.11 0.88, 1.4 .38
MR-Egger regression 0.30 0.06, 1.43 .129 1.00 0.37, 2.67 .999 0.88 0.55, 1.39 .578
MR-PRESSO methoda  n/a n/a n/a n/a n/a n/a n/a n/a n/a
Heterogeneityb  I2 = 0%; Cochrane's Q = 81; 
Phet = .998
I2 14%; Cochrane's Q 140; Phet = .103 I
2 16%; Cochrane's Q 143; Phet = .078
Pleiotropyc  Intercept = 0.061; Ppleiotropy = .127 Intercept 0.006; Ppleiotropy = .818 Intercept 0.003; Ppleiotropy = .797
aThere was no corrected estimate (n/a) if no outlier was identified. One outlier was identified and removed in the analysis of colorectal cancer based 
on UK Biobank (P value for the distortion test was.815) and two outliers were identified and removed in the analysis of gastric cancer based on 
Biobank Japan (P value for the distortion test was.137). 
bWe observed significant heterogeneity among used SNPs in the analysis of colorectal cancer based on UK Biobank and gastric cancer based on 
Biobank Japan (Phet < .05). 
cPleiotropy was measured by the intercept from MR-Egger regression. Pleiotropy was not detected in any analysis (all P > .05). 
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Biobank, BioBank Japan, and FinnGen, though the association with 
gastric cancer was not statistically significant after correcting for 
multiple testing (Figure 1). The combined odds ratio was 0.85 (95% 
confidence interval, 0.75, 0.97; P = .016) for esophageal cancer, 0.90 
(95% confidence interval, 0.82, 0.98; P = .020) for gastric cancer, and 
0.91 (95% confidence interval, 0.86, 0.96; P = .001) for colorectal 
cancer for one unit increase in log-transformed odds of allergic dis-
ease. The associations were consistent across data sources with the 
exception of the estimate for gastric cancer in FinnGen which was 
above one but with a broad confidence interval that overlapped the 
estimates in UK Biobank and BioBank Japan. Results were consis-
tent in sensitivity analyses for all three cancer outcomes (Table 1).
A potential limitation arises from the fact that we used an instru-
ment for liability to allergic disease that was developed using genetic 
data from individuals of European ancestry and applied to a Japanese 
population. However, a consistent effect of risk alleles of SNPs for 
allergic disease on asthma in BioBank Japan indicates a high validity 
of used instrumental variables and a negligible population bias. In ad-
dition, a robust pattern of established associations in both Asian and 
European populations suggested that the associations were portable 
across populations of distinct ancestries. A further limitation of this 
work is that we cannot make specific inferences about the impact of 
food allergies on cancer risk.
In summary, this MR study supports a protective effect of al-
lergic disease against esophageal and colorectal cancer and possi-
bly gastric cancer. This finding may be useful for further laboratory 
studies to understand the immunological pathways involved in gas-
trointestinal tract carcinogenesis.
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